QZLX gel alleviates psoriasiform inflammation through immunomodulatory effects involving PD-1/PD-L1/SHP2 signaling axis.
It is demonstrated that QZLX gel alleviates psoriasis-like inflammation and skin symptoms, and these effects are associated with modulation of the PD-1/PD-L1/SHP2 axis and PI3K-AKT signaling pathway.